Dr Karl Baumgart BSc (Med), MB, BS, PhD, FRACP, FRCPA
Immunologist in Allergy and Clinical Immunology; Director of Immunopathology at Douglass Hanly Moir Pathology, Sydney; Member of the Australasian Society of Clinical Immunology and Allergy.
ALLERGIC rhinitis is a major global public health issue. It affects up to 40% of the Australian population and its prevalence is increasing each year.1,2
The effects of allergic rhinitis are vastly underestimated and have a significant impact on quality of life and